COFCO Biotechnology Co., Ltd. (SHE:000930)

COFCO Biotechnology Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Income	-123.61	38.37	25.13	-601.63	1,059	1,130
Depreciation & Amortization	511.94	511.94	506.58	491.84	458.19	449.81
Other Amortization	21.21	21.21	19.83	17.37	17.96	20.79
Loss (Gain) From Sale of Assets	-60.1	-60.1	0.15	-1.16	145.82	203.22
Asset Writedown & Restructuring Costs	44.19	44.19	2.27	54.45	13.3	21.48
Loss (Gain) From Sale of Investments	-33.88	-33.88	-42.25	10.33	4.08	-41.92
Provision & Write-off of Bad Debts	1.61	1.61	35.97	-0.15	0.21	0.21
Other Operating Activities	31.54	545.07	546.17	641.07	278.15	347.89
Change in Accounts Receivable	326.97	326.97	-199.05	1,011	-1,052	2,418
Change in Inventory	433.37	433.37	-653.64	679.83	83.07	760.34
Change in Accounts Payable	74.79	74.79	-42.82	-287.46	-329.12	-414.53
Change in Other Net Operating Assets	-	-	-4.86	-14.35	-6.27	8.67
Operating Cash Flow	1,172	1,847	155.81	1,958	708.44	4,842
Operating Cash Flow Growth	-10.81%	1085.69%	-92.04%	176.38%	-85.37%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Capital Expenditures	-737.98	-673.93	-483.3	-634.52	-565.78	-1,110
Sale of Property, Plant & Equipment	65.42	61.44	16.44	166.32	246.92	270.39
Divestitures	-	-	-	-	-	160.52
Investment in Securities	102.85	102.85	-	-	5.6	-
Other Investing Activities	147.64	41.82	90.22	-104.8	12.68	10.96
Investing Cash Flow	-422.07	-467.82	-376.64	-572.99	-300.58	-667.9

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Long-Term Debt Issued	-	6,969	6,877	7,565	6,437	8,253
Long-Term Debt Repaid	-	-7,693	-6,115	-7,275	-6,521	-11,627
Net Debt Issued (Repaid)	-592.63	-723.48	761.5	289.33	-84.59	-3,374
Common Dividends Paid	-71.17	-83.06	-93.48	-1,172	-554.75	-277.34
Other Financing Activities	15	18.95	-156.58	2.91	45.05	-50.03
Financing Cash Flow	-648.79	-787.6	511.45	-880.04	-594.28	-3,702

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Foreign Exchange Rate Adjustments	-31.64	21.72	27.52	11.07	40.37	-4.32
Net Cash Flow	69.46	613.75	318.14	516.02	-146.05	467.69

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Free Cash Flow	433.97	1,174	-327.49	1,323	142.66	3,732
Free Cash Flow Growth	-48.17%	-	-	827.69%	-96.18%	-
Free Cash Flow Margin	2.55%	6.70%	-1.63%	6.49%	0.72%	15.84%
Free Cash Flow Per Share	0.23	0.63	-0.18	0.72	0.08	2.02
Levered Free Cash Flow	1,896	2,437	-425.38	1,267	192.1	3,071
Unlevered Free Cash Flow	1,947	2,490	-359.84	1,337	246.55	3,170

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash Income Tax Paid	247.17	266.94	291.39	214.77	227.63	603.27
Change in Working Capital	779.07	779.07	-938.03	1,346	-1,268	2,711

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error